SlateStone Wealth’s ProShares Ultra Health Care RXL Stock Holding History

SlateStone Wealth’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,600	Closed	-$242K	–	210
2019 Q4	$242K	Buy	+7,600	New	+$213K	0.06%	190
2019 Q3	–	Sell	-8,000	Closed	-$210K	–	181
2019 Q2	$210K	Buy	+8,000	New	+$198K	0.06%	166

Other funds holding RXL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wealth Advisors Rancho Santa Fe, California $223M AUM 32.56% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SlateStone Wealth's RXL Position: Q1 2020 in Review

SlateStone Wealth sold out of ProShares Ultra Health Care (RXL) in Q1 2020, closing a stake of 7,600 shares — an estimated $242K sold.

SlateStone Wealth first reported a position in RXL in Q2 2019 and held it in 2 quarters. The position peaked at $242K in Q4 2019. 20 funds tracked by Wall St. Rank hold RXL as of Q1 2020.

SlateStone Wealth reported no remaining ProShares Ultra Health Care position as of Q1 2020 after selling out during the quarter.
SlateStone Wealth sold 7,600 ProShares Ultra Health Care shares in Q1 2020, an estimated $242K.
SlateStone Wealth first reported a position in ProShares Ultra Health Care in Q2 2019 and held it in 2 quarters.
SlateStone Wealth's ProShares Ultra Health Care position peaked at $242K in Q4 2019.
20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2020.

Based on SlateStone Wealth's 13F filing for Q1 2020, filed 28 Apr 2020.